Millendo Therapeutics, Inc. (MLND) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for MLND in the last 30 days. The most recent was published Jul 8, 2021.
Latest news
25 items- 13D/GSEC Form SC 13G filed by Millendo Therapeutics, Inc.SC 13G - Tempest Therapeutics, Inc. (0001544227) (Subject)
- SECMillendo Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Tempest Therapeutics, Inc. (0001544227) (Filer)
- INSIDERSEC Form 3: Versant Venture Capital VI, L.P. claimed ownership of 2,176,411 units of Common Stock3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4 filed by Xu Stella4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4 filed by Woiwode Thomas4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4 filed by NICHOL GEOFFREY4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4 filed by Pellizzari Christine A4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Pellizzari Christine A3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
- 13D/GSEC Form SC 13G filed by Millendo Therapeutics, Inc.SC 13G - Tempest Therapeutics, Inc. (0001544227) (Subject)
- SECSEC Form 8-K/A filed by Millendo Therapeutics, Inc. (Amendment)8-K/A - Millendo Therapeutics, Inc. (0001544227) (Filer)
- INSIDERSEC Form 4: Whiting Samuel was granted 201 units of Common Stock4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Whiting Samuel3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4: Xu Stella was granted 579,710 units of Common Stock4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4: Dubensky Thomas W. was granted 111,343 units of Common Stock4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4 filed by RAAB MICHAEL4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4: Woiwode Thomas was granted 2,176,411 units of Common Stock4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4 filed by Brady Stephen R4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 4: Lorenzo Pierre was granted 53 units of Common Stock4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Xu Stella3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Brady Stephen R3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by RAAB MICHAEL3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Woiwode Thomas3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Lorenzo Pierre3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- INSIDERSEC Form 3 filed by Dubensky Thomas W.3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
- SECMillendo Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Changes in Control of Registrant, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Millendo Therapeutics, Inc. (0001544227) (Filer)
MLND FAQ
6 questionsWhat is the latest news on MLND?
Quantisnow has not tracked any new filings, ratings or press releases for MLND in the last 30 days. The most recent wire item was published on July 8, 2021.Where does MLND stock trade?
Millendo Therapeutics, Inc. (MLND) is listed on NASDAQ.What sector and industry is MLND in?
Millendo Therapeutics, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.When did Millendo Therapeutics, Inc. go public?
Millendo Therapeutics, Inc. (MLND) completed its IPO in n/a.What companies are similar to MLND?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare MLND side-by-side with any of them on Quantisnow.How can I track MLND on Quantisnow?
Quantisnow aggregates Millendo Therapeutics, Inc. 's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MLND to receive live email and push alerts on every new disclosure.